杨湛南,方文,黄茜
YANG Zhannan,FANG Wen,HUANG Qian

• 1:邢台市第三医院心内三科
• 2:贵州医科大学医学检验学院
• 3:邢台市人民医院消化科

摘要(Abstract)：

目的:探讨幽门螺杆菌(Hp)感染与冠心病患者抗血小板药物治疗后发生上消化道出血的关系,观察根除Hp对降低此类患者上消化道出血风险的效果。方法:420例冠心病不稳定心绞痛患者,根据C-14尿素呼气试验结果分为Hp阳性组(n=270)和Hp阴性组(n=150),又将Hp阳性组分为Hp阳性治疗组(n=170)和Hp阳性未治疗组(n=100),所有患者均采用常规氯吡格雷、阿司匹林进行抗血小板治疗,Hp阳性治疗组患者采用四联用药方案进行Hp根除治疗;3组患者于治疗后1年时随访,记录上消化道出血和贫血情况、检测血肌酐、谷丙转氨酶(ALT)、血浆凝血酶原时间(PT)、血红蛋白(Hb)含量,记录再发心绞痛、非致死性心肌梗死和心力衰竭心脏不良事件发生率。结果:1年时随访结果显示,17例Hp阳性患者(6.30%)发生上消化道出血,其中Hp阳性治疗组3例(1.76%),Hp阳性未治疗组14例(14%),Hp阴性患者无上消化道出血病例,Hp阳性未治疗组患者上消化道出血发生率高于Hp阳性治疗组和Hp阴性组(P<0.05);与Hp阴性组和Hp阳性治疗组比较,Hp阳性未治疗组贫血发生率增高、Hb含量降低(P<0.05),而Hp阳性治疗组与Hp阴性组患者贫血发生率及Hb含量比较差异无统计学意义(P>0.05);3组患者PT、血肌酐及ALT水平比较,差异无统计学意义(P>0.05);3组患者治疗后1年时的随访结果显示,Hp阴性、Hp阳性治疗和未治疗患者再发心绞痛、非致死性心肌梗死及心力衰竭心脏不良事件发生率比较,差异无统计学意义(P>0.05)。结论:抗Hp治疗可降低冠心病合并Hp感染抗血小板治疗患者上消化道出血的风险,改善贫血程度。
Objective: To investigate the correlation of Helicobacter pylori( Hp) infection and upper gastrointestinal hemorrhage by anti-platelet therapy in patients with coronary heart disease,and observe the effect of Hp eradication to prophylaxis upper gastrointestinal hemorrhage. Methods: 420 patients with unstable coronary heart disease; according to14 C breath test,patients were divided into Hp positive groups( 270 cases) and Hp negative group( 150 cases); Hp positive group were further divided into Hp positive treatment group( 170 cases) and Hp positive non-treatment group( 100 cases); all patients adopted conventional clopidogrel and aspirin to carry out antiplatelet treatment,Hp positive treatment group adopted 4 combination medication therapy to eradicate Hp; 3 groups of patients were followed-up for one year,and recording UGI hemorrhage and anemia situation,testing creatinine,ALT,PT,Hb content; recording repeated angina pectoris,non-fatal myocardial infarction and heart failure adverse incidence rate. Results: 1 year follow-up visit showed that 17 Hp positive patients( 6. 30%)was found upper gastrointestinal hemorrhage in treatment group( 3 cases,1. 76%) and non-treatment group( 14,14%); Hp negative group found no cases of upper gastrointestinal hemorrhage,Hp positive untreated patients were found with higher incidence rate of upper gastrointestinal hemorrhage than Hp positive treated patients and negative group( P < 0. 05); compared with Hp negative group and Hp positive group treatment group,there was increased incidence rate of anemia and decreased Hb content in Hp positive untreated group( P < 0. 05),while anemia incidence rate and Hb content comparison of Hp positive treatment group and Hp negative group showed no statistical significance( P > 0. 05); PT,creatinine and ALT level comparison of three groups showed no statistical significance( P > 0. 05); 1year follow-up visit after treatment showed that repeated angina pectoris,non-fatal myocardial infarction and heart failure adverse incidence rate no statistical significance( P > 0. 05). Conclusion: Helicobacter pylori infection can increase the risk of upper gastrointestinal hemorrhage in coronary heart disease,and eradicating Hp therapy can reduce this risk and improve anemia degree.

关键词(KeyWords)： 心脏病;冠状动脉疾病;幽门螺杆菌;出血,上消化道;C-14尿素呼气试验;阿司匹林;氯吡格雷;抗血小板治疗
heart disease;coronary artery disease;Helicobacter pylori;bleeding;upper gastrointestinal tract;14C-urea breath test;aspirin;clopidogrel;antiplatelet therapy

Abstract:

Keywords:

基金项目(Foundation): 河北省卫生厅科研基金(ZD20140452)

作者(Author): 杨湛南,方文,黄茜
YANG Zhannan,FANG Wen,HUANG Qian

DOI: 10.19367/j.cnki.1000-2707.2017.09.012

参考文献(References)：

• [1]张庭友,尚芙蓉.老年脑梗死与幽门螺杆菌相关性研究[J].中国预防医学杂志,2016(11):853-856.
• [2]朱秀芳,黄茜,杨湛南,等.幽门螺杆菌与冠心病的关系[J].中国老年学杂志,2016(21):5273-5275.
• [3]李忠明,夏平达,周琴.幽门螺杆菌感染与冠心病患者上消化道出血的相关性研究[J].中华医院感染学杂志,2015(10):2188-2190.
• [4]颜红兵,马长生.美国冠心病诊断于治疗指南[M].北京:中国环境科学出版社,2006:11-43.
• [5]陈菲,潘晨,王瑞睿,等.3种四联方案根除幽门螺杆菌的效果及安全性观察[J].贵州医科大学学报,2017(5):588-591.
• [6]肖江梅,孟祥杰.首次根除幽门螺杆菌失败后不同补救方法的疗效分析[J].检验医学与临床,2016(1):79-80.
• [7]刘静,张铁亮,戴运辉,等.幽门螺杆菌感染与经皮冠状动脉介入治疗术后抗血小板治疗诱发上消化道出血的关系[J].中国循环杂志,2016(11):1060-1063.
• [8]张蓉,孙静.老年冠心病患者根治幽门螺杆菌感染的临床价值[J].中国医药导报,2015(31):89-92.
• [9]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.抗血小板治疗中国专家共识[J].中华心血管病杂志,2013(3):183-194.
• [10]Fiscella K,Winters PC,Mendoza M,et al.Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease[J].J Gen Intern Med,2015(2):155-160.
• [11]张秋瓒,王艳荣,杨倩,等.双联抗血小板治疗合并上消化道出血的危险因素[J].世界华人消化杂志,2015(16):2600-2604.
• [12]Meltzer AC,Winter LE,Kulie P,et al.Treating gastritis,pepticulcer disease,and dyspepsia in the emergency department:the feasibility and patient-reported outcomes of testing and treating for helicobacterpylori infection[J].Ann Emerg Med,2015(2):131-139.
• [13]侯小琴,吴建华,夏先考,等.冠心病患者幽门螺杆菌感染对血清氧化低密度脂蛋白及冠状动脉病变的影响[J].实用预防医学,2015(5):544-547.
• [14]Focks JJ,Brouwer MA,van Oijen MG.Concomitant use of clopidogrel and proton pump inhibitors:impact on platelet function and clinical outcome-a systematic review[J].Heart,2013,99(8):520-527.
• [15]Fang J,George MG,Gindi RM,et al.Use of low-dose aspirin as secondary prevention of atherosclerotic cardiovascular disease in US adults(from the National Health Interview Survey,2012)[J].Am J Cardiol,2015(7):895-900.
• [16]万运方,王红玲.幽门螺杆菌跟治疗法对长期应用抗凝药物患者上消化道再出血的影响[J].武汉大学学报(医学版),2015(4):600-603.
• [17]傅眀炜,姚道阔,王永亮,等.急性心肌梗死患者幽门螺杆菌感染情况及其与上消化道出血的关系[J].新乡医学院学报,2014(2):111-113,116.
• [18]Irwin J,Ferguson R,Weilert F,et al.Incidence of upper gastrointestinal haemorrhage in Maori and New Zealand European ethnic groups,2001-2010[J].Intern Med J,2014(8):735-741.
• [19]吕永铭,冀晓庆,王淑亮,等.克拉霉素治疗幽门螺杆菌感染患者的临床疗效研究[J].中华医院感染学杂志,2015(9):1997-1998,2001.
• [20]杨麒臻,周力,刘苓.含阿莫西林和铋剂的四联方案根除幽门螺杆菌的疗效观察[J].贵阳医学院学报,2015(10):1703-1706.

文章评论(Comment)：